跳至主要内容
临床试验/NCT00902512
NCT00902512已完成4 期

Relative Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations In Healthy Volunteers Under Fasting Conditions.

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
AUC0-T and Cmax of sildenafil

研究概览

简要总结

the pharmacokinetics of sildenafil following single doses of sildenafil CT administered with and without water is similar relative to the conventional oral tablet of sildenafil administered with water.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Only healthy male volunteers in the 18-40 age range will be included.
  • At the selection visit allowed normal range for vital signs will be: Blood pressure (with the subject sitting down) 90-130mm Hg systolic and 60-90
  • The volunteers' health condition will be determined from their complete clinical history by doctors at the clinical research site and lab test results by certified clinical laboratories mm Hg diastolic, heart rate 55-100 bpm , respiratory rate 14-20 respirations per minute.

排除标准

  • Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing) disease or clinical findings at Screening.
  • Treatment with a PDE-5 inhibitor within the 4 days preceding the first dose of study medication
  • History of hypersensitivity to sildenafil citrate or any components of its formulations

研究组 & 干预措施

Treatment C

Active Comparator

Sildenafil 100 mg CT administered without water

干预措施: Blood samples for the analysis of sildenafil in plasma (Other)

Treatment A

Active Comparator

Viagra® 100 mg tablet, administered with water

干预措施: Treatment A (Drug)

Treatment A

Active Comparator

Viagra® 100 mg tablet, administered with water

干预措施: Blood samples for the analysis of sildenafil in plasma (Other)

Treatment B

Active Comparator

Sildenafil 100 mg CT administered with water

干预措施: Treatment B (Drug)

Treatment B

Active Comparator

Sildenafil 100 mg CT administered with water

干预措施: Blood samples for the analysis of sildenafil in plasma (Other)

Treatment C

Active Comparator

Sildenafil 100 mg CT administered without water

干预措施: Treatment C (Drug)

结局指标

主要结局

AUC0-T and Cmax of sildenafil

时间窗: 28 days

次要结局

  • AUC0-inf of sildenafil(28 days)
  • Tmax and half-life of sildenafil(28 days)
  • Adverse events and vital signs(28 days)

研究者

发起方
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study Of Bioavailability Of Two Sildenafil 100mg... | 临床试验